Fundraising FoxReNetX Bio
New Haven, US · Delaware corporation · 2 known investors
Find your way into ReNetX Bio
Sign up to see every warm intro you have to ReNetX Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ReNetX Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
DW
David WurzerBoard director
GH
Gregory HoBoard director
JP
John PuzissBoard director
Investors · 2
Connecticut InnovationsreportedNew Haven · $500K – $2M
How we know: funding news · prweb.com · Not right? Tell us
Spring Mountain CapitalreportedNew York
How we know: funding news · prweb.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 3 rounds · 2017–2019
▶$2.8MraisedSep 2020 · 6 investors · BiotechnologyRule 506(b)
▶$2.8MraisedSep 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory HoDirector
- Erika SmithExecutive Officer, Director
- John PuzissDirector
- George MaynardExecutive Officer
- David WurzerDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedJul 2019 · 6 investors · BiotechnologyRule 506(b)
▶$3.2MraisedJul 2019 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David WurzerDirector
- John PuzissDirector
- Erika R. SmithExecutive Officer, Director
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$425KraisedDec 2017 · 5 investors · BiotechnologyRule 506(b)
▶$425KraisedDec 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JOHN PUZISSDirector
- DAVID WURZERDirector
- ERIKA R. SMITHExecutive Officer, Director
- Offering amount
- $450K
- Amount sold
- $425K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2013 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded ReNetX Bio?
- ReNetX Bio was founded by Erika Smith.
- Who are ReNetX Bio's investors?
- ReNetX Bio's investors include Connecticut Innovations, Spring Mountain Capital.
- How much funding has ReNetX Bio raised?
- ReNetX Bio has disclosed $6.4M raised across 3 rounds.
- Where is ReNetX Bio headquartered?
- ReNetX Bio is headquartered in New Haven, US.